FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Leo Pharma Taclonex Recall

Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0

LEO PHARMA INC · Madison, NJ

Risk level
Class III
Reported by FDA
Feb 22, 2017
Recall ID
D-0477-2017
Check your lot numberHow we source this data

Summary

Leo Pharma recalled Taclonex starting Jan 16, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0477-2017 on Feb 22, 2017. Reason: Labeling: Incorrect or missing package insert: the affected product was packaged with an out-of-date package insert (PI) dated February 2014. Status: Terminated.

Why it was recalled

Labeling: Incorrect or missing package insert: the affected product was packaged with an out-of-date package insert (PI) dated February 2014.

Product description

Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC 50222-501-06), and (b)120 g (50222-501-66) tubes, Rx Only, Manufactured by: LEO Laboratories Ltd., 285 Cashel Road, Dublin 12 Ireland, Distributed by: LEO Pharma Inc. 1 Sylvan Way, Parsippany, NJ 07054.

Lot numbers, UPCs & expiration codes

Lot #: (a): EK9025, Exp. 2/28/2017; EL1057, Exp. 3/31/2017; EL4637, Exp. 6/30/2017; EM0825B, Exp. 11/30/2017; EM3992, Exp. 1/31/2019; A22902, Exp. 5/31/2019; A31838, Exp. 9/30/2019 Lot #:EK7007A, EK7007AA, Exp. 1/31/2017; EL2024, EL2979, Exp. 5/31/2017; EL8069, Exp. 10/31/2017; EA20780AA, Exp. 5/31/2019.

Where it was sold

Nationwide within US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0477-2017
Classification
Class III
Status
Terminated
Recall initiated
Jan 16, 2017
FDA report date
Feb 22, 2017
Quantity
189,610 units
Recall type
Voluntary: Firm initiated
Recalling firm
LEO PHARMA INC

Original FDA data

Every field from FDA enforcement report D-0477-2017, exactly as published.

Show all FDA fields
City
Madison
State
NJ
Status
Terminated
Country
United States
Event ID
76370
Address
7 Giralda Farms
Code information
Lot #: (a): EK9025, Exp. 2/28/2017; EL1057, Exp. 3/31/2017; EL4637, Exp. 6/30/2017; EM0825B, Exp. 11/30/2017; EM3992, Exp. 1/31/2019; A22902, Exp. 5/31/2019; A31838, Exp. 9/30/2019 Lot #:EK7007A, EK7007AA, Exp. 1/31/2017; EL2024, EL2979, Exp. 5/31/2017; EL8069, Exp. 10/31/2017; EA20780AA, Exp. 5/31/2019.
Postal code
07940-1051
Report date
Feb 22, 2017
Product type
Drugs
Recall number
D-0477-2017
Classification
Class III
Recalling firm
LEO PHARMA INC
Product quantity
189,610 units
Termination date
Dec 12, 2017
Reason for recall
Labeling: Incorrect or missing package insert: the affected product was packaged with an out-of-date package insert (PI) dated February 2014.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC 50222-501-06), and (b)120 g (50222-501-66) tubes, Rx Only, Manufactured by: LEO Laboratories Ltd., 285 Cashel Road, Dublin 12 Ireland, Distributed by: LEO Pharma Inc. 1 Sylvan Way, Parsippany, NJ 07054.
Distribution pattern
Nationwide within US
Recall initiation date
Jan 16, 2017
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Feb 15, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0477-2017, published Feb 22, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls